Nihon Kohden (NHNKY) 10.9000 $NHNKY Nihon Kohde
Post# of 273242
Nihon Kohden Expands U.S. Operations with New Pennsylvania Facility
BusinessWire - Thu Jun 09, 12:02PM CDT
Nihon Kohden, a U.S. market leader in precision medical products and services, today announced that it is enhancing its support of customers across the U.S. by opening a technical support call center in Allentown, Pa. The company's new 6,000-square-foot facility will complement its headquarters-based technical support call center in Irvine, Calif., allowing it to provide a rapid and robust response to customers across all U.S. time zones, especially to major institutions in and around the East Coast.
Global ECG Devices Market to Grow at a CAGR Of 4.1% between 2016 and 2024, With APAC Expected to Flourish as Market: Persistence Market Research
PR Newswire Europe - Thu Jun 09, 7:02AM CDT
NEW YORK, June 9, 2016 /PRNewswire/ --
Nihon Kohden Awarded New Equipment, Supplies Contract with Premier, Inc.
BusinessWire - Wed May 04, 6:00AM CDT
Nihon Kohden, a market leader in precision medical products and services, has extended its neurology contract with Premier, Inc., a leading healthcare improvement company with an alliance of 3,600 U.S. hospitals and 120,000 other providers. The agreement, effective May 1, 2016, continues the long-standing relationship Nihon Kohden has with Premier.
Nihon Kohden Introduces Life Scope G9 Monitor, Designed to Be Personalized to Individual Patient Need
BusinessWire - Wed Apr 27, 6:00AM CDT
Nihon Kohden, a U.S. market leader in precision medical products and services, today unveiled its new Life Scope G9, a bedside monitor that provides comprehensive parameter observation and allows clinicians to quickly and easily customize the monitor to each patient regardless of health status or care setting. Created with the goal of improving outcomes and enhancing the patient experience, the multimodality Life Scope G9 is fully optimized for use in any clinical setting as part of Nihon Kohden's premium-as-standard philosophy.
Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment
BusinessWire - Wed Apr 13, 6:00AM CDT
Nihon Kohden, a U.S. market leader in precision medical products and services, has launched a new website as part of its continuing effort to meet the needs of the dynamic U.S. healthcare market. The new website, which was unveiled today, provides greater insight into Nihon Kohden's integrated line of products that help professionals across the healthcare system improve the quality of care while controlling costs. The website coincides with the company's brand redesign.
Brain Monitoring Market - Expected to Reach $11.3 Billion by 2020 from $7.5 Billion in 2015
M2 - Tue Feb 09, 9:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/sxx3mh/brain_monitoring) has announced the addition of the "Brain Monitoring Market - Global Forecast to 2020" report to their offering. Factors such as the increasing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative diseases, technological advancements in devices and growing incidence of traumatic brain injuries are driving market growth. On the other hand shortage of trained professionals, high cost of complex devices, unfavorable reimbursement policies and concerns regarding the accuracy of diagnostic devices may restrict market growth. In 2015, North America is expected to dominate the market. The high market share of this region is attributed to rising incidence of various neurodegenerative and sleep disorders, availability of insurance coverage for brain monitoring techniques, presence of strong sales and distribution network of leading neurodiagnostic companies, and government initiatives to support technological advancements in the field of neurosciences. Scope of the Report: By Product: - Devices - Accessories By Procedure: - Invasive - Non-invasive By Therapeutic Application: - Epilepsy - Dementia - Parkinson's Disease - Huntington's Disease - Headache Disorders - Stroke - Traumatic Brain Injuries - Sleep Disorders - Other Therapeutic Applications By End User: - Hospitals - Neurological Centers and Institutions - Ambulatory Surgical Centers and Clinics - Ambulances - Diagnostic Centers - Other End Users By Region: - North America - Europe - Asia - Rest of the World (RoW) Companies Mentioned: - Advanced Brain Monitoring, Inc. - CAS Medial Systems, Inc. - Compumedics Limited - Electrical Geodesics, Inc. - GE Healthcare - Medtronic PLC - Natus Medical Inc. - Nihon Kohden Corporation - Philips Healthcare - Siemens Healthcare Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Brain Monitoring Market, By Product 7 Brain Monitoring Market, By Procedure 8 Brain Monitoring Market, By Therapeutic Application 9 Brain Monitoring Market, By End User 10 Brain Monitoring Market, By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/sx...monitoring
BABY: 42.61 (+0.73), MDT: 85.86 (+0.20)
Pressure Monitoring Market Forecast to 2020 - Rising Prevalence of Chronic & Acute Diseases - Expected to Reach $8.04 Billion
M2 - Fri Feb 05, 6:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/l5tcpt/pressure) has announced the addition of the "Pressure Monitoring Market - Forecast to 2020" report to their offering. The pressure monitoring market is expected to reach $8.04 Billion by 2020 from $6.3 Billion in 2015, at a CAGR of 5.0%. Pressure monitoring plays an important role in detecting the health problems of a patient. The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma. Increase in the prevalence of the above mentioned diseases and growing aging population have increased the need for pressure monitoring and control in the market. The major factors responsible for the growth of the pressure monitoring are the rising prevalence of chronic and acute diseases, growth of aging population, new product launches, increase in the lifestyle related diseases, and technological advancements. Due to these factors, the demand for pressure monitoring is increasing. On the other hand, lack of trained professionals, short shelf life of the device, accuracy of devices has may restrain the growth of the market. Increasing urbanization resulting into increased pollution levels, rising prevalence of chronic diseases and acute diseases, changing lifestyle, growing aging population and technological advancements are factors driving growth in the market. On the other hand, high cost of technological development, concerns regarding the accuracy of these devices, short shelf life of devices and accessories, availability of low cost devices from the local market, and lack of training for using the devices may hinder the growth of the market. Companies Mentioned: - A&D Medical - Becton, Dickinson and Company - Dragerwerk Ag & Co. KGAA - GE Healthcare - Medtronic PLC - Nihon Kohden Corporation - Nonin Medical Inc. - Philips Healthcare - Smiths Medical - Welch Allyn Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 By Product Type 7 By Procedure 8 By Therapeutic Application 9 By End User 10 By Region 11 Competitive Landscape 12 Company Profiles For more information visit http://www.researchandmarkets.com/research/l5tcpt/pressure
MDT: 85.86 (+0.20)
China Respiratory Measurement Devices Market Outlook to 2021 - Capnographs, Spirometers and Pulse Oximeter Systems.
M2 - Thu Feb 04, 7:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/tb9hxx/china_respiratory) has announced the addition of the "China Respiratory Measurement Devices Market Outlook to 2021" report to their offering. "China Respiratory Measurement Devices Market Outlook to 2021", provides key market data on the China Respiratory Measurement Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments Capnographs, Spirometers and Pulse Oximeter Systems. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Respiratory Measurement Devices market. - Global corporate-level profiles of key companies operating within the China Respiratory Measurement Devices market. - Key players covered include Medtronic plc, Philips Respironics, Inc., Smiths Medical, Masimo Corporation, Draegerwerk AG & Co. KGaA, ResMed Inc., Nihon Kohden Corporation, Nonin Medical, Inc. and others. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Respiratory Measurement Devices Market, China 4 Overview of Key Companies in China, Respiratory Measurement Devices Market 5 Respiratory Measurement Devices Market Pipeline Products 6 Appendix For more information visit http://www.researchandmarkets.com/research/tb...espiratory
MASI: 59.37 (+0.75), RMD: 64.59 (-0.37)
United Kingdom Respiratory Measurement Devices Market Outlook Report 2015 - Capnographs, Spirometers and Pulse Oximeter Systems 2007-2021
M2 - Thu Feb 04, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/2l27zp/united_kingdom) has announced the addition of the "United Kingdom Respiratory Measurement Devices Market Outlook to 2021" report to their offering. "United Kingdom Respiratory Measurement Devices Market Outlook to 2021", provides key market data on the United Kingdom Respiratory Measurement Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments Capnographs, Spirometers and Pulse Oximeter Systems. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Respiratory Measurement Devices market. - Global corporate-level profiles of key companies operating within the United Kingdom Respiratory Measurement Devices market. - Key players covered include Medtronic plc, Philips Respironics, Inc., Smiths Medical, Masimo Corporation, Draegerwerk AG & Co. KGaA, ResMed Inc., Nihon Kohden Corporation, Nonin Medical, Inc. and others. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Respiratory Measurement Devices Market, United Kingdom 4 Overview of Key Companies in United Kingdom, Respiratory Measurement Devices Market 5 Respiratory Measurement Devices Market Pipeline Products 6 Appendix For more information visit http://www.researchandmarkets.com/research/2l...ed_kingdom
MASI: 59.37 (+0.75), RMD: 64.59 (-0.37)
United States Respiratory Measurement Devices (Capnographs, Spirometers and Pulse Oximeter Systems) Market Outlook to 2021
M2 - Thu Feb 04, 5:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/8v4ttr/united_states) has announced the addition of the "United States Respiratory Measurement Devices Market Outlook to 2021" report to their offering. "United States Respiratory Measurement Devices Market Outlook to 2021", provides key market data on the United States Respiratory Measurement Devices market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments Capnographs, Spirometers and Pulse Oximeter Systems. The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021. - 2014 company shares and distribution shares data for Respiratory Measurement Devices market. - Global corporate-level profiles of key companies operating within the United States Respiratory Measurement Devices market. - Key players covered include Medtronic plc, Philips Respironics, Inc., Smiths Medical, Masimo Corporation, Draegerwerk AG & Co. KGaA, ResMed Inc., Nihon Kohden Corporation, Nonin Medical, Inc. and others. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Respiratory Measurement Devices Market, United States 4 Overview of Key Companies in United States, Respiratory Measurement Devices Market 5 Respiratory Measurement Devices Market Pipeline Products 6 Financial Deals Landscape 7 Appendix For more information visit http://www.researchandmarkets.com/research/8v...ted_states
MASI: 59.37 (+0.75), RMD: 64.59 (-0.37)
U.S. POC/Decentralized Hematology and Flow Cytometry Markets Report 2016
M2 - Wed Feb 03, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt3qx4/2016_u_s) has announced the addition of the "2016 U.S. POC/Decentralized Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers Companies Mentioned - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - CellaVision - Horiba - Iris Diagnostics/Danaher - Nihon Kohden - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/zt3qx4/2016_u_s
A: 44.94 (-0.50), DHR: 76.60 (-0.20)
2015-2019 POC/Point-of-Care Coagulation Testing Market Report
M2 - Wed Feb 03, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/9jg9pv/20152019) has announced the addition of the "2015-2019 POC/Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 450-page report contains 53 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Companies Mentioned - Abbott - ADI/American Diagnostica/Sekisui - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Kreatech/Leica - Kyowa Medex - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/9jg9pv/20152019 About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
A: 44.94 (-0.50), DHR: 76.60 (-0.20)
2016 Emerging U.S. POC/Point-of-Care Testing Markets Report
M2 - Wed Feb 03, 8:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/j9p9cf/2016_emerging_u_s) has announced the addition of the "2016 Emerging U.S. POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies" report to their offering. This 1,007-page report provides comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic instrument and reagent suppliers develop more effective business, R&D and marketing strategies. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of the emerging POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for chemistry, immunodiagnostic, microbiology, hematology and coagulation procedures by market segment: - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers By test category: - Routine and Special Chemistry - Microbiology/Infectious Diseases - Hematology - Flow Cytometry - Coagulation - Immunoproteins - Drugs of Abuse - TDM - Endocrine Function - Tumor Markers Competitive Assessments - Abbott - ADI/American Diagnostica/Sekisui - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Cepheid - Chrono-Log - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Kyowa Medex - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/j9...erging_u_s
SQNM: 2.39 (-0.01), A: 44.94 (-0.50), CPHD: 52.65 (unch), DHR: 76.60 (-0.20)
Nihon Kohden America Receives Great Place to Work(R) Certification
BusinessWire - Wed Feb 03, 6:00AM CST
Nihon Kohden America, a U.S.-market leader in medical instrumentation solutions, was certified as a great workplace today by the independent analysts at Great Place to Work(R) Institute, the global authority on high-trust, high-performance workplace cultures.
Global POC/Point-of-Care Infectious Disease Testing Market 2016
M2 - Mon Feb 01, 10:03AM CST
Research and Markets (http://www.researchandmarkets.com/research/j68rtr/2016) has announced the addition of the "2016 POC/Point-of-Care Infectious Disease Testing Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers" report to their offering. This new 835-page report contains 80 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC infectious disease testing market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment: - Physician Offices/Group Practices - Emergency Rooms - Ambulatory Care Centers - Surgery Centers - Birth Centers Sales and Market Share Analysis - Market shares of major infectious disease diagnostic reagent and instrument suppliers. Current and Emerging Products - Analysis of infectious disease diagnostic tests performed in POC testing locations. - Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. Technology Review - Emerging technologies and their applications for POC testing. - Comprehensive listings of companies developing or marketing coagulation testing technologies and products, by assay. Competitive Assessments - Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D. Strategic Recommendations - Specific opportunities for new infectious disease testing instruments and reagent systems with potentiallysignificant market appeal during the next five years. - Design criteria for POC testing products. - Alternative business expansion strategies. - Potential market entry barriers and risks. Companies Mentioned - Abbott - ADI/American Diagnostica/Sekisui - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Bio-Rad - Cepheid - Chrono-Log - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech/Leica - Kyowa Medex - Lonza - Mackay Life Sciences - Matritech - Nihon Kohden - Ortho-Clinical Diagnostics - Polartechnics - Polymedco - Qiagen - Roche - SDIX - Sequenom - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher - Tosoh - Wako - Zycare/Alere For more information visit http://www.researchandmarkets.com/research/j68rtr/2016 About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SQNM: 2.39 (-0.01), A: 44.94 (-0.50), CPHD: 52.65 (unch), DHR: 76.60 (-0.20), HOLX: 37.66 (-0.09)
Patient Monitoring Device/Equipment/System Market by Product, End-User - Global Forecast to 2020
M2 - Tue Jan 26, 10:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/wvvhjm/patient) has announced the addition of the "Patient Monitoring Device/Equipment/System Market by Product, End-User - Global Forecast to 2020" report to their offering. The patient monitoring devices market is expected to grow at a CAGR of 5.6% to reach $24,762 Million by 2020. The market is driven by rise in the geriatric population, growing incidences of lifestyle diseases, increased use of home and remote monitors, and technological advancements like portability of equipment. However, the unpredictable reimbursement policies will restrain the growth of this market to an extent. The segments for companies to invest in the near future will be neuromonitors, remote patient monitoring (RPM) devices, and respiratory monitors. The patient monitoring devices market is segmented into nine major segments: - Hemodynamic - Neurology - Cardiac - Respiratory - Fetal and neonatal - Multiparameter - Remote patient monitors - Temperature - Weight management monitors. With respect to end-users the patient monitoring devices market is divided into hospitals, home, and others such as research and diagnostics centers. Under this segment the home healthcare segment will observe high growth as a result of increased measures including stringent regulations and policies set by the government adopted by healthcare authorities to decrease the number of hospital admissions. Companies Mentioned: - Abbott Laboratories - Ge Healthcare - Honeywell International, Inc. - Lifewatch Ag - Medtronic Plc - Nihon Kohden Corporation - Omron Corporation - Philips Healthcare - Roche Diagnostics - Siemens Healthcare Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Hemodynamic Monitoring Devices 7 Neuromonitoring Devices 8 Cardiac Monitoring Devices 9 Fetal and Neonatal Monitoring Devices 10 Respiratory Monitoring Devices 11 Multi-Parameter Monitoring Devices 12 Remote Patient Monitoring Devices Market 13 Weight Monitoring Devices 14 Temperature Monitoring Devices 15 Patient Monitoring Devices Market, By Region 16 Competitive Landscape 17 Company Profiles For more information visit http://www.researchandmarkets.com/research/wvvhjm/patient
ABT: 41.29 (+0.17), MDT: 85.86 (+0.20), HON: 114.20 (-1.08)
UK Cardiovascular Monitoring Systems Market Report - Analysis, Technologies, Trends & Forecasts 2007-2020
M2 - Tue Jan 12, 8:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/7s58sw/uk_cardiovascular) has announced the addition of the "UK Cardiovascular Monitoring Systems Market Growth Trends, 2007 - 2020" report to their offering. This research report provides key market trends, market forecasts and competitive scenario of the cardiovascular monitoring systems in the UK through 2020. The product categories covered in this report include: - ECG Monitoring Equipment (Electrocardiogram) - ECG Stress Testing Systems - Holter Monitoring System - Event Monitoring Systems Key Topics Covered: - The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. - Highlights and compares key product categories for growth trends and revenue forecast. - Market size, annualized revenue and unit sales for each product category from 2007 to 2020. - Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. - Market share of companies. - Average selling price ($) for each product type (2007 to 2020). - Recent Events and Developments. Benefits of this Report: - Build business strategy by identifying the high growth and attractive market categories. - Develop competitive strategy based on competitive landscape. - Design capital investment strategies based on forecasted high potential segments. - Identify potential business partners, acquisition targets and business buyers. - Plan for a new product launch and inventory in advance. - Prepare management and strategic presentations using the market data. - To review unbiased and independent assessment of the market data. Companies Mentioned: - LifeWatch, Corp. - Cardiac Science Corporation - Fukuda Denshi - GE Healthcare - Nihon Kohden Corporation - OSI Systems, Inc. - Philips Medical Systems - Welch Allyn Inc. Report Structure: 1. Table of Contents 2. Introduction 3. Scope of the Report 4. UK Market for Cardiovascular Monitoring Systems, 2007-2020 5. Recent Events and Developments 6. Appendix For more information visit http://www.researchandmarkets.com/research/7s...iovascular
OSIS: 63.46 (+0.13)
2016 Global Hematology & Flow Cytometry Market Report - Analysis, Technologies, Opportunities & Forecasts - Companies Mentioned: Abbott, Becton Dickinson, Roche & More
M2 - Tue Jan 12, 4:27AM CST
Research and Markets (http://www.researchandmarkets.com/research/qslspr/competing_in_the) has announced the addition of the "Competing in the 2016 Global Hematology and Flow Cytometry Market" report to their offering. This new report contains 700 pages, 250 tables, and provides information not available from any other published source, including: - Specimen forecasts by market segment - Test volume forecasts by assay and market segment - Reagent and instrument sales forecasts by market segment - Instrument placements and installed base by manufacturer and model - Sales and market shares of reagent and instrument suppliers The report will help current suppliers and potential market entrants identify and evaluate emerging opportunities in the hematology and flow cytometry markets during the next five years. The report explores future marketing and technological trends in seven countries; provides market share estimates, test volume forecasts, and instrument placements; compares features of leading analyzers; profiles major competitors and emerging market entrants; and suggests specific product and marketing opportunities facing suppliers. During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine. Contains 700 pages and 250 tables. Companies Mentioned: - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - CellaVision - Horiba - Iris Diagnostics/Danaher - Nihon Kohden - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/qs...ing_in_the
A: 44.94 (-0.50), DHR: 76.60 (-0.20)
US Female & Neonatal Diagnostic Device Market Report - Analysis, Technologies & Forecasts 2016
M2 - Mon Jan 11, 6:50AM CST
Research and Markets (http://www.researchandmarkets.com/research/cnfsfw/us_female_and) has announced the addition of the "US Female and Neonatal Diagnostic Device Market Report Suite - 2016" report to their offering. This report includes analysis and forecasting for the markets for bone densitometry (central and peripheral), breast biopsy devices (spring-loaded core needles, VABB devices, as well as breakdowns for stereotactic X-ray, ultrasound and MRI guidance), breast imaging (mammography, breast ultrasound, breast MRI coils, gamma imaging and positron emission mammography), OB/GYN ultrasound imaging, fetal and neonatal monitoring (hospital, alternate and home-use), as well as incubators and warmers. This report covers devices used for bone densitometry, breast biopsy, breast imaging, OB/GYN ultrasound imaging, fetal and neonatal monitoring, infant warmers and incubators. The majority of these market segments will see stable growth throughout the forecast period of this report. In 2015, the largest segment of this market was represented by breast imaging. Companies Mentioned: - Hologic - GE Healthcare - Philips Healthcare - Siemens Healthcare - Mammotome (Devicor) - C.R. Bard - Samsung Medison - Dr?ger Medical - Norland, at Swissray - Laborie - AGFA Healthcare - Assured Imaging Mobile Mammography - Atmos Medical BeamMed - Biosound Esaote - BK Medical - CareFusion - Carestream Health - CAS Medical - CMR-Naviscan - Dilon Technologies - Dr?ger Medical - Fischer-Giotto - Fujifilm Medical - Fujifilm Sonosite - Fukuda Denshi - Gamma Medica Inc. - Hitachi Aloka Medical America Inc. - Huntleigh Healthcare - Intact Medical - International Biomedical - Konica Minolta - Laborie - Loan Oak Medical Technologies - Machnet - Mindray - Natus Medical - Nihon Kohden - Osteometer Meditech - Planmed OY - Samsung Medison - Scion Medical Technologies - SonoCine - Spacelabs Healthcare - SuperSonic Imagine - Toshiba America Medical Systems - Zonare Medical Systems Report Structure: 1. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET 2. RESEARCH METHODOLOGY 3. U.S. FEMALE AND NEONATAL DIAGNOSTIC DEVICE MARKET OVERVIEW 4. PROCEDURE NUMBERS 5. BONE DENSITOMETRY MARKET 6. BREAST BIOPSY DEVICE MARKET 7. BREAST IMAGING EQUIPMENT MARKET 8. OBSTETRICS AND GYNECOLOGY ULTRASOUND EQUIPMENT MARKET 9. FETAL AND NEONATAL MONITORING DEVICE MARKET 10. INFANT WARMER AND INCUBATOR MARKET 11. GYNECOLOGICAL CHAIR MARKET 12. ABBREVIATIONS 13. PROCEDURAL CODES For more information visit http://www.researchandmarkets.com/research/cn...female_and
BABY: 42.61 (+0.73), CFN: 59.91 (-0.06), MDSY: 1.25 (-0.05), HOLX: 37.66 (-0.09)